Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1986-12-19
1994-10-04
Draper, Garnette D.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
530300, 530402, 530413, 53038822, 5303892, 530810, 530811, 530812, 530808, 530351, 530820, 435 691, 435 7021, 435 702, 435 71, C07K 1500
Patent
active
053527720
ABSTRACT:
A new cellular protein produced by activated T cells and involved in the high affinity binding of interleukin-2 has been discovered. This protein has a molecular weight of about 75,000 (Mr) and is further characterized as having an affinity for IL-2 (in the absence of other receptor proteins) of about 10.sup.-9 molar and is substantially unreactive with anti-Tac antibodies. This new cellular protein, referred to herein as the ".alpha. chain," is believed to interact with the previously isolated 55,000 dalton receptor protein (referred to herein as the ".beta. chain") to form the high affinity interleukin-2 receptor which triggers the growth and mitosis of T cells during an immune response. Methods for isolating and purifying the .alpha. chain protein are disclosed herein as well as techniques for cloning and expressing the protein and related materials. Techniques for raising monoclonal antibodies to such proteins are also disclosed. Diagnostic and therapeutic uses for the novel receptor protein (or particular epitopes thereof) as well as monoclonal antibodies (or active fragments) reactive therewith are proposed.
REFERENCES:
patent: 4411993 (1983-10-01), Gillis
patent: 4578335 (1986-03-01), Urdal et al.
patent: 4816565 (1989-03-01), Hong et al.
Fuji et al., J. Immunol 137, 1986, pp. 1552-1556.
Osawa et al. Eur. J. Immunol. 14, 1984, 394-376.
Burns et al. J. Exp. Med. 161, 1985, pp. 1063-1078.
Tsudo et al. PNAS 83, 1986, pp. 9694-9698.
Kuo et al., J. Immunol. 137, 1986, pp. 1541-1551.
Leonard et al., PNAS 80, 1983, pp. 6959-6961.
Marrack et al., Scientific American Feb. 1987, pp. 36-45.
Malek et al., PNAS 80, 1983, pp. 5694-5698.
Samelson et al., PNAS 80, 1983, pp. 6972-6976.
Robb et al., J. Exp. Med., vol. 154, pp. 1455-1474 (1981).
Leonard et al., Nature, vol. 300, pp. 267-269 (1982).
Leonard et al., Nature, vol. 311, pp. 626-631 (1984).
Nikaido et al., Nature, vol. 311, pp. 632-635 (1984).
Rob et al., J. of Exp. Med., vol. 160, pp. 1126.1146 (1984).
Smith et al., Proc. Natl. Acad. Sci., vol. 82, pp. 864-868 (1985).
Yodoi et al., J. of Immunology, vol. 134, pp. 1623-1630.
Greene et al., J. of Exp. Med., vol. 162, pp. 363-368.
Hatakeyama et al., Nature, vol. 318, pp. 467-470 (1985).
Sabe et al., Mol. Biol. Med., vol. 2, pp. 379-396 (1986).
Kondo et al., Nature, vol. 320, pp. 75-77 (1986).
Sharon et al., Science, vol. 234, pp. 859-863 (1986).
Draper Garnette D.
The Trustees of Dartmouth College
United States of America
LandOfFree
75 Kilodalton interleukin-2 receptor proteins and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 75 Kilodalton interleukin-2 receptor proteins and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 75 Kilodalton interleukin-2 receptor proteins and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-582290